Cardiovascular protection by angiotensin-converting enzyme 2: A new paradigm

Future Cardiology

Volumn 4, Issue 2, 2008, Pages 175-182

  Ferreira, Anderson J ^a,b   Prada, José A Hernández ^a   Ostrov, David A ^a   Raizada, Mohan K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiotensin II; Angiotensin (1 7); Angiotensin converting enzyme; Cardiology; Cardiovascular diseases; Hypertension; Mas receptor

Indexed keywords

1 [[2 (DIMETHYLAMINO)ETHYL]AMINO] 4 (HYDROXYMETHYL) 7 [[(4 METHYLPHENYL)SULFONYL]OXY] 9H XANTHEN 9 ONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; N ETHYLCARBAMOYL 3 [4 (5 FORMYL 4 METHOXY 2 PHENYL 1 IMIDAZOLYLMETHYL)PHENYL] 5 ISOBUTYL 2 THIOPHENESULFONAMIDE; UNCLASSIFIED DRUG;

BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; DISEASE MODEL; DRUG MECHANISM; ENZYME ACTIVITY; GENETIC VARIABILITY; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN DEATH; UNSPECIFIED SIDE EFFECT; VASOCONSTRICTION;

EID: 40649098647     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/14796678.4.2.175     Document Type: Review

References (59)